WHO Launches Global Megatrial of the Four Most Promising Coronavirus Treatments
Share
[aggregation-styles]
Science
Could any of these drugs hold the key to saving coronavirus disease 2019 (COVID-19) patients from serious harm or death? On Friday, the World Health Organization (WHO) announced a large global trial, called SOLIDARITY, to find out whether any can treat infections with the new coronavirus for the dangerous respiratory disease.
It’s an unprecedented effort—an all-out, coordinated push to collect robust scientific data rapidly during a pandemic. The study, which could include many thousands of patients in dozens of countries, has been designed to be as simple as possible so that even hospitals overwhelmed by an onslaught of COVID-19 patients can participate.
With about 15% of COVID-19 patients suffering from severe disease and hospitals being overwhelmed, treatments are desperately needed. So rather than coming up with compounds from scratch that may take years to develop and test, researchers and public health agencies are looking to repurpose drugs already approved for other diseases and known to be largely safe.
They’re also looking at unapproved drugs that have performed well in animal studies with the other two deadly coronaviruses, which cause severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
Read More →
Science
Could any of these drugs hold the key to saving coronavirus disease 2019 (COVID-19) patients from serious harm or death? On Friday, the World Health Organization (WHO) announced a large global trial, called SOLIDARITY, to find out whether any can treat infections with the new coronavirus for the dangerous respiratory disease.
It’s an unprecedented effort—an all-out, coordinated push to collect robust scientific data rapidly during a pandemic. The study, which could include many thousands of patients in dozens of countries, has been designed to be as simple as possible so that even hospitals overwhelmed by an onslaught of COVID-19 patients can participate.
With about 15% of COVID-19 patients suffering from severe disease and hospitals being overwhelmed, treatments are desperately needed. So rather than coming up with compounds from scratch that may take years to develop and test, researchers and public health agencies are looking to repurpose drugs already approved for other diseases and known to be largely safe.
They’re also looking at unapproved drugs that have performed well in animal studies with the other two deadly coronaviruses, which cause severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
Read More →
By Kai Kupferschmidt and Jon Cohen | 22 Mar 2020
RELATED TOPICS:
Former Bulldog QB Jake Haener: I Have a ‘Rare Form of Skin Cancer’
Sports /
7 hours ago
The Many Names of GOP Vice Presidential Nominee JD Vance
Latest /
8 hours ago
Companies Cut Prices to Boost Sales, Consumers Respond
Business /
8 hours ago
Warner Bros. Discovery Sues NBA for Not Accepting Its Matching Offer
Sports /
9 hours ago
Will Bonta Election Lawsuit Reverse the Will of Fresno County Voters?
Politics /
9 hours ago
Latest
Videos
Crime /
6 hours ago
Fresno Man Sentenced to 29 Years for Sexually Assaulting Children and Dog
Sports /
6 hours ago
Bulldogs’ Two-Position Standout Tommy Hopfe Signs With Rockies
Sports /
7 hours ago
Former Bulldog QB Jake Haener: I Have a ‘Rare Form of Skin Cancer’
Latest /
8 hours ago